VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q57032579 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241020233149.0
008 241020nneanz||abbn n and d
035 ‎‡a (WKP)Q57032579‏
024 ‎‡a 0000-0003-4207-0739‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q57032579‏
100 0 ‎‡a Maria R Lopez-Alvarez‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Maria R Lopez-Alvarez‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A comprehensive analysis of e-CAS cell line reveals they are mouse macrophages.‏
670 ‎‡a Author's Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance‏
670 ‎‡a Author's Allele-specific recognition by LILRB3 and LILRA6 of a cytokeratin 8-associated ligand on necrotic glandular epithelial cells.‏
670 ‎‡a Author's Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients‏
670 ‎‡a Author's Association of monoclonal expansion of Epstein-Barr virus-negative CD158a+ NK cells secreting large amounts of gamma interferon with hemophagocytic lymphohistiocytosis.‏
670 ‎‡a Author's CD28 and KIR2D receptors as sensors of the immune status in heart and liver transplantation‏
670 ‎‡a Author's Copy number and nucleotide variation of the LILR family of myelomonocytic cell activating and inhibitory receptors‏
670 ‎‡a Author's Divergences in KIR2D+ natural killer and KIR2D+CD8+ T-cell reconstitution following liver transplantation‏
670 ‎‡a Author's Expression of HLA molecules on peripheral blood lymphocytes: a useful monitoring parameter in cardiac transplantation‏
670 ‎‡a Author's HBV and HCV infections and acute rejection differentially modulate CD95 and CD28 expression on peripheral blood lymphocytes after liver transplantation‏
670 ‎‡a Author's HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.‏
670 ‎‡a Author's Immunogenicity of phospholipase A2 toxins and their role in Streptococcus equi pathogenicity‏
670 ‎‡a Author's Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection.‏
670 ‎‡a Author's Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma‏
670 ‎‡a Author's Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: is the relevance of HLA-A locus matching being underestimated?‏
670 ‎‡a Author's KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.‏
670 ‎‡a Author's KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.‏
670 ‎‡a Author's LILRA6 copy number variation correlates with susceptibility to atopic dermatitis‏
670 ‎‡a Author's Long-term problems related to immunosuppression.‏
670 ‎‡a Author's NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome‏
670 ‎‡a Author's NKG2D Polymorphism in Melanoma Patients from Southeastern Spain‏
670 ‎‡a Author's Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing‏
670 ‎‡a Author's Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy.‏
670 ‎‡a Author's qKAT: a high-throughput qPCR method for KIR gene copy number and haplotype determination‏
670 ‎‡a Author's Refinement of the equine influenza model in the natural host: A meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity‏
670 ‎‡a Author's SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles‏
670 ‎‡a Author's Strangles: A modern clinical view from the 17th century.‏
670 ‎‡a Author's TGF-beta1 gene polymorphism in liver graft recipients‏
670 ‎‡a Author's The Immunity Gap Challenge: Protection against a Recent Florida Clade 2 Equine Influenza Strain‏
909 ‎‡a (orcid) 0000000342070739‏ ‎‡9 1‏
919 ‎‡a allelespecificrecognitionbylilrb3andlilra6ofacytokeratin8associatedligandonnecroticglandularepithelialcells‏ ‎‡A Allele-specific recognition by LILRB3 and LILRA6 of a cytokeratin 8-associated ligand on necrotic glandular epithelial cells.‏ ‎‡9 1‏
919 ‎‡a immunogenicityofphospholipasea2toxinsandtheirroleinstreptococcusequipathogenicity‏ ‎‡A Immunogenicity of phospholipase A2 toxins and their role in Streptococcus equi pathogenicity‏ ‎‡9 1‏
919 ‎‡a impactofrecipienthla100inlivertransplantaprotectiveeffectofhlacw07onacuterejection‏ ‎‡A Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection.‏ ‎‡9 1‏
919 ‎‡a increasednumberofcytotoxiccd3+cd28gammadeltatcellsinperipheralbloodofpatientswithcutaneousmalignantmelanoma‏ ‎‡A Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma‏ ‎‡9 1‏
919 ‎‡a influenceofhumanleukocyteantigenmismatchingonrejectiondevelopmentandallograftsurvivalinlivertransplantationistherelevanceofhlaalocusmatchingbeingunderestimated‏ ‎‡A Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: is the relevance of HLA-A locus matching being underestimated?‏ ‎‡9 1‏
919 ‎‡a kirgenemismatchingandkir100ligandsinlivertransplantationconsequencesforshorttermliverallograftinjury‏ ‎‡A KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.‏ ‎‡9 1‏
919 ‎‡a kirgenevariabilityincutaneousmalignantmelanomainfluenceofkir2dhla100pairingsondiseasesusceptibilityandprognosis‏ ‎‡A KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.‏ ‎‡9 1‏
919 ‎‡a lilra6copynumbervariationcorrelateswithsusceptibilitytoatopicdermatitis‏ ‎‡A LILRA6 copy number variation correlates with susceptibility to atopic dermatitis‏ ‎‡9 1‏
919 ‎‡a longtermproblemsrelatedtoimmunosuppression‏ ‎‡A Long-term problems related to immunosuppression.‏ ‎‡9 1‏
919 ‎‡a nkcelleducationintumorimmunesurveillancednam1kirreceptorratiosaspredictivebiomarkersforsolidtumoroutcome‏ ‎‡A NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome‏ ‎‡9 1‏
919 ‎‡a nkg2dpolymorphisminmelanomapatientsfromsoutheasternspain‏ ‎‡A NKG2D Polymorphism in Melanoma Patients from Southeastern Spain‏ ‎‡9 1‏
919 ‎‡a overexpressionofkirinhibitoryligandshla1determinesthatimmunosurveillanceofmyelomadependsondiverseandstrongnkcelllicensing‏ ‎‡A Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing‏ ‎‡9 1‏
919 ‎‡a posttransplantincreaseinsolublehumanleukocyteantigengassociatedwithnonseverecardiacallograftvasculopathy‏ ‎‡A Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy.‏ ‎‡9 1‏
919 ‎‡a qkatahighthroughputqpcrmethodforkirgenecopynumberandhaplotypedetermination‏ ‎‡A qKAT: a high-throughput qPCR method for KIR gene copy number and haplotype determination‏ ‎‡9 1‏
919 ‎‡a refinementoftheequineinfluenzamodelinthenaturalhostametaanalysistodeterminethebenefitsofindividualnebulisationforexperimentalinfectionandvaccineevaluationinthefaceofdecreasedstrainpathogenicity‏ ‎‡A Refinement of the equine influenza model in the natural host: A meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity‏ ‎‡9 1‏
919 ‎‡a spesanovelsuperantigenanditspotentialasavaccineadjuvantagainststrangles‏ ‎‡A SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles‏ ‎‡9 1‏
919 ‎‡a stranglesamodernclinicalviewfromthe17century‏ ‎‡A Strangles: A modern clinical view from the 17th century.‏ ‎‡9 1‏
919 ‎‡a tgfbeta1genepolymorphisminlivergraftrecipients‏ ‎‡A TGF-beta1 gene polymorphism in liver graft recipients‏ ‎‡9 1‏
919 ‎‡a immunitygapchallengeprotectionagainstarecentfloridaclade2equineinfluenzastrain‏ ‎‡A The Immunity Gap Challenge: Protection against a Recent Florida Clade 2 Equine Influenza Strain‏ ‎‡9 1‏
919 ‎‡a activatingkirsoneducatednkcellssupportdownregulationofcd226andinefficienttumorimmunosurveillance‏ ‎‡A Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance‏ ‎‡9 1‏
919 ‎‡a comprehensiveanalysisofecascelllinerevealstheyaremousemacrophages‏ ‎‡A A comprehensive analysis of e-CAS cell line reveals they are mouse macrophages.‏ ‎‡9 1‏
919 ‎‡a hla100matchingandlivertransplantsdonorrecipientgenotypesinfluenceearlyoutcomeandcd8+kir2d+tcellsrecuperation‏ ‎‡A HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.‏ ‎‡9 1‏
919 ‎‡a hbvandhcvinfectionsandacuterejectiondifferentiallymodulatecd95andcd28expressiononperipheralbloodlymphocytesafterlivertransplantation‏ ‎‡A HBV and HCV infections and acute rejection differentially modulate CD95 and CD28 expression on peripheral blood lymphocytes after liver transplantation‏ ‎‡9 1‏
919 ‎‡a expressionofhlamoleculesonperipheralbloodlymphocytesausefulmonitoringparameterincardiactransplantation‏ ‎‡A Expression of HLA molecules on peripheral blood lymphocytes: a useful monitoring parameter in cardiac transplantation‏ ‎‡9 1‏
919 ‎‡a divergencesinkir2d+naturalkillerandkir2d+cd8+tcellreconstitutionfollowinglivertransplantation‏ ‎‡A Divergences in KIR2D+ natural killer and KIR2D+CD8+ T-cell reconstitution following liver transplantation‏ ‎‡9 1‏
919 ‎‡a copynumberandnucleotidevariationofthelilrfamilyofmyelomonocyticcellactivatingandinhibitoryreceptors‏ ‎‡A Copy number and nucleotide variation of the LILR family of myelomonocytic cell activating and inhibitory receptors‏ ‎‡9 1‏
919 ‎‡a cd28andkir2dreceptorsassensorsoftheimmunestatusinheartandlivertransplantation‏ ‎‡A CD28 and KIR2D receptors as sensors of the immune status in heart and liver transplantation‏ ‎‡9 1‏
919 ‎‡a associationofmonoclonalexpansionofepsteinbarrvirusnegativecd158a+nkcellssecretinglargeamountsofgammainterferonwithhemophagocyticlymphohistiocytosis‏ ‎‡A Association of monoclonal expansion of Epstein-Barr virus-negative CD158a+ NK cells secreting large amounts of gamma interferon with hemophagocytic lymphohistiocytosis.‏ ‎‡9 1‏
919 ‎‡a analysisofkir2dreceptorsonperipheralbloodlymphocytesfromlivergraftrecipients‏ ‎‡A Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 BNE|XX1153841
996 ‎‡2 CAOONL|ncf11955013
996 ‎‡2 RERO|A012785089
996 ‎‡2 ISNI|0000000107527399
996 ‎‡2 LC|no2018040182
996 ‎‡2 SUDOC|055834876
996 ‎‡2 CAOONL|ncf11539765
996 ‎‡2 LC|n 83034963
996 ‎‡2 LC|n 2009077116
996 ‎‡2 NII|DA19446504
996 ‎‡2 LC|n 96102244
996 ‎‡2 PTBNP|1669214
996 ‎‡2 SUDOC|168934957
996 ‎‡2 LC|nb2007025165
996 ‎‡2 BNE|XX5442343
996 ‎‡2 LC|n 2017046092
996 ‎‡2 ISNI|0000000356738859
996 ‎‡2 ISNI|0000000061122395
996 ‎‡2 LC|no2020020240
996 ‎‡2 NUKAT|n 2004050642
996 ‎‡2 BNE|XX864956
996 ‎‡2 BNC|981060973474906706
996 ‎‡2 BNE|XX917452
996 ‎‡2 BNE|XX5655505
996 ‎‡2 PLWABN|9812830957605606
996 ‎‡2 LC|n 88620458
996 ‎‡2 DNB|1057437514
996 ‎‡2 ISNI|0000000059366593
996 ‎‡2 SUDOC|112616739
996 ‎‡2 LC|n 90636635
996 ‎‡2 BNC|981058520576406706
996 ‎‡2 B2Q|0001069758
996 ‎‡2 ISNI|0000000116970595
996 ‎‡2 BNF|18110129
996 ‎‡2 ISNI|0000000034794567
996 ‎‡2 DNB|1157154778
996 ‎‡2 NII|DA17170887
996 ‎‡2 BNC|981061104051806706
996 ‎‡2 BNE|XX5613081
996 ‎‡2 ISNI|0000000050823153
996 ‎‡2 BNE|XX5872827
996 ‎‡2 BNE|XX1033890
996 ‎‡2 BNC|981058518399706706
996 ‎‡2 BNE|XX1374666
996 ‎‡2 BNE|XX1348465
996 ‎‡2 LC|ns2017002733
996 ‎‡2 ISNI|0000000002220390
996 ‎‡2 BIBSYS|4105528
996 ‎‡2 BNE|XX1062744
996 ‎‡2 ISNI|0000000082487107
996 ‎‡2 PLWABN|9813626855905606
996 ‎‡2 LC|no2017070280
996 ‎‡2 DNB|1057683221
996 ‎‡2 ISNI|0000000039960763
996 ‎‡2 NUKAT|n 2023045347
996 ‎‡2 LC|ns2024002721
996 ‎‡2 SUDOC|268457034
996 ‎‡2 ISNI|0000000048377107
996 ‎‡2 LC|n 2020027407
996 ‎‡2 ISNI|0000000066374575
996 ‎‡2 PLWABN|9813197498905606
996 ‎‡2 LC|no2009163198
996 ‎‡2 ISNI|0000000060863829
996 ‎‡2 LC|no2012103109
996 ‎‡2 BNE|XX4615763
996 ‎‡2 ISNI|0000000453035856
996 ‎‡2 NUKAT|n 2016173387
996 ‎‡2 LC|n 97040971
996 ‎‡2 BNE|XX5553466
996 ‎‡2 LC|n 2011006573
996 ‎‡2 BNE|XX1631910
996 ‎‡2 DNB|1140023241
996 ‎‡2 LC|ns2024000644
996 ‎‡2 BNE|XX1006075
996 ‎‡2 PTBNP|225868
996 ‎‡2 PTBNP|1145761
996 ‎‡2 BNC|981058581156006706
996 ‎‡2 BNCHL|10000000000000000834299
996 ‎‡2 SUDOC|237775824
996 ‎‡2 BNE|XX1675814
996 ‎‡2 LC|nr2001002426
996 ‎‡2 SELIBR|301515
996 ‎‡2 DNB|1057682179
996 ‎‡2 BNF|16145951
996 ‎‡2 ISNI|0000000078275590
996 ‎‡2 LC|no2016066480
996 ‎‡2 NUKAT|n 2006085202
996 ‎‡2 BNCHL|10000000000000000805530
996 ‎‡2 LIH|LNB:B_r__a__y_;=CY
996 ‎‡2 ISNI|0000000023667407
996 ‎‡2 BNE|XX885094
996 ‎‡2 BNF|14413244
996 ‎‡2 BNE|XX1751342
996 ‎‡2 BNF|14502178
996 ‎‡2 DNB|1157164269
996 ‎‡2 BNF|14649295
996 ‎‡2 DNB|1139650769
996 ‎‡2 ISNI|000000045120509X
996 ‎‡2 PTBNP|1394812
996 ‎‡2 BNE|XX882515
996 ‎‡2 SUDOC|146630408
996 ‎‡2 BNE|XX1655214
996 ‎‡2 SUDOC|163610959
996 ‎‡2 LC|no2023069172
996 ‎‡2 ISNI|0000000059408909
996 ‎‡2 BIBSYS|1512647517739
996 ‎‡2 ISNI|0000000500587566
996 ‎‡2 LC|nr2005023572
996 ‎‡2 BNE|XX1036432
996 ‎‡2 BNCHL|10000000000000000190133
996 ‎‡2 LC|no2010121662
996 ‎‡2 NII|DA09899069
996 ‎‡2 LC|n 2001105620
996 ‎‡2 J9U|987007321141905171
996 ‎‡2 RERO|A012645553
996 ‎‡2 LC|no2018119445
996 ‎‡2 BNCHL|10000000000000000843681
996 ‎‡2 LC|no2018044311
996 ‎‡2 DNB|1057538299
996 ‎‡2 LC|no2022065217
996 ‎‡2 LC|no2009137115
996 ‎‡2 DNB|1203774192
996 ‎‡2 BNE|XX1192653
996 ‎‡2 BNF|12257056
996 ‎‡2 BNE|XX993258
996 ‎‡2 LC|no2012116302
996 ‎‡2 LC|n 90673219
996 ‎‡2 CAOONL|ncf13701851
996 ‎‡2 PLWABN|9810703037505606
996 ‎‡2 SUDOC|253848008
996 ‎‡2 BNF|16256934
996 ‎‡2 ISNI|0000000474354581
996 ‎‡2 ISNI|0000000374517654
996 ‎‡2 LC|no2019072801
996 ‎‡2 ISNI|0000000061116091
996 ‎‡2 DNB|115730298X
996 ‎‡2 ISNI|0000000067670536
996 ‎‡2 LC|no 92027957
996 ‎‡2 BNE|XX1477531
996 ‎‡2 DNB|1249227798
996 ‎‡2 BNE|XX1398669
996 ‎‡2 ISNI|0000000079716677
996 ‎‡2 NII|DA02922118
996 ‎‡2 SUDOC|251424383
996 ‎‡2 BNE|XX1747974
996 ‎‡2 BNE|XX4613162
996 ‎‡2 BNE|XX965891
996 ‎‡2 ISNI|0000000042284188
996 ‎‡2 NYNYRILM|384211
996 ‎‡2 BNE|XX961883
996 ‎‡2 LC|no2013038320
996 ‎‡2 LC|n 2023002743
996 ‎‡2 RERO|A023832684
996 ‎‡2 NKC|jx20120110023
996 ‎‡2 LC|nr 97006366
996 ‎‡2 LC|no2023117925
996 ‎‡2 BLBNB|000557788
996 ‎‡2 DNB|1057342122
996 ‎‡2 LC|n 84193970
996 ‎‡2 NTA|262193647
996 ‎‡2 J9U|987007401516405171
996 ‎‡2 BNE|XX5724320
996 ‎‡2 BNE|XX1454848
996 ‎‡2 NUKAT|nx2022598574
996 ‎‡2 BNE|XX901973
996 ‎‡2 BNE|XX1328550
996 ‎‡2 LC|n 2001000178
996 ‎‡2 DNB|1157210074
996 ‎‡2 SUDOC|226793656
996 ‎‡2 DNB|188426809
996 ‎‡2 LC|n 92080033
996 ‎‡2 DNB|1056705736
996 ‎‡2 BNE|XX870665
996 ‎‡2 SUDOC|140517030
996 ‎‡2 BNE|XX843658
996 ‎‡2 BIBSYS|5094210
996 ‎‡2 ISNI|0000000140799417
996 ‎‡2 NTA|09135305X
996 ‎‡2 ISNI|0000000023063793
996 ‎‡2 DNB|188359761
996 ‎‡2 BNCHL|10000000000000000837520
996 ‎‡2 LC|nr2002001846
996 ‎‡2 BNC|981058520553506706
996 ‎‡2 DNB|1056495146
996 ‎‡2 BNF|17001676
996 ‎‡2 BNE|XX1009724
996 ‎‡2 ISNI|0000000067794563
996 ‎‡2 ISNI|000000011075623X
996 ‎‡2 CAOONL|ncf11905031
996 ‎‡2 ISNI|0000000060687992
996 ‎‡2 BNE|XX1297988
996 ‎‡2 DNB|128329017
996 ‎‡2 SUDOC|078015375
996 ‎‡2 BNE|XX4927725
996 ‎‡2 LC|no2019118969
996 ‎‡2 LC|n 95031359
996 ‎‡2 BLBNB|000385488
996 ‎‡2 BNC|981058515057206706
996 ‎‡2 LC|n 83157886
996 ‎‡2 ISNI|0000000383889791
996 ‎‡2 BNC|981061102424906706
996 ‎‡2 ISNI|0000000072518301
996 ‎‡2 DNB|1056190566
996 ‎‡2 LC|n 81123328
996 ‎‡2 LC|n 2020045722
996 ‎‡2 PTBNP|274775
996 ‎‡2 NTA|072060549
996 ‎‡2 BNC|981058596043306706
996 ‎‡2 LC|no 99071679
996 ‎‡2 LC|no2019105112
996 ‎‡2 BNE|XX878649
996 ‎‡2 SUDOC|165839732
996 ‎‡2 BNE|XX1093515
996 ‎‡2 DNB|132322811
996 ‎‡2 DNB|1316243710
996 ‎‡2 BNE|XX5723419
996 ‎‡2 ISNI|0000000034879528
996 ‎‡2 BNE|XX4580123
996 ‎‡2 BNE|XX1740710
996 ‎‡2 SUDOC|154976083
996 ‎‡2 J9U|987007371388205171
996 ‎‡2 BNE|XX1020807
996 ‎‡2 ISNI|0000000497384433
996 ‎‡2 ISNI|0000000073050464
996 ‎‡2 BNE|XX5166218
996 ‎‡2 LC|ns2015004620
996 ‎‡2 LC|no 99026967
996 ‎‡2 NTA|229859852
996 ‎‡2 DNB|1124245995
996 ‎‡2 ISNI|000000011556734X
996 ‎‡2 BNE|XX1481945
996 ‎‡2 BNE|XX1045636
996 ‎‡2 BNE|XX1167773
996 ‎‡2 ISNI|000000005995001X
996 ‎‡2 PLWABN|9813699478905606
996 ‎‡2 PTBNP|1913726
996 ‎‡2 LC|no2015049732
996 ‎‡2 LC|no2024045564
996 ‎‡2 BNCHL|10000000000000000111722
996 ‎‡2 BNF|12356277
996 ‎‡2 SUDOC|032271395
996 ‎‡2 LC|nr 95040179
996 ‎‡2 BNC|981060918507206706
996 ‎‡2 PTBNP|1657928
996 ‎‡2 BNE|XX1611591
996 ‎‡2 BNC|981058522710506706
996 ‎‡2 DNB|132221314
996 ‎‡2 DNB|1020740701
996 ‎‡2 ISNI|0000000080555911
996 ‎‡2 RERO|A011268204
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏